A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

Heterologous prime-boost immunisation with RTS,S/AS02A and the poxvirus MVA-CS was evaluated in 18 healthy malaria-naïve subjects in Oxford. Both priming with RTS,S and boosting MVA-CS, and the reverse, were found to be safe and well tolerated. T cell responses as measured by IFN-gamma ex vivo ELISP...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Dunachie, S, Walther, M, Vuola, J, Webster, D, Keating, S, Berthoud, T, Andrews, L, Bejon, P, Poulton, I, Butcher, G, Watkins, K, Sinden, R, Leach, A, Moris, P, Tornieporth, N, Schneider, J, Dubovsky, F, Tierney, E, Williams, J, Heppner, D, Gilbert, S, Cohen, J, Hill, A
Formato:	Journal article
Idioma:	English
Publicado em:	2006

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

Registos relacionados